Basit öğe kaydını göster

dc.contributor.authorErcan, Suleyman
dc.contributor.authorDavutoglu, Vedat
dc.contributor.authorAltunbas, Gokhan
dc.contributor.authorInanc, Ibrahim Halil
dc.contributor.authorKaplan, Mehmet
dc.contributor.authorOylumlu, Muhammed
dc.contributor.authorKoc, Ibrahim
dc.contributor.authorYuce, Murat
dc.contributor.authorOzer, Orhan
dc.contributor.authorSoydinc, Serdar
dc.date.accessioned2019-12-10T11:23:39Z
dc.date.available2019-12-10T11:23:39Z
dc.date.issued2014
dc.identifier.issn0160-9289
dc.identifier.urihttps://doi.org/10.1002/clc.22239
dc.identifier.urihttp://hdl.handle.net/11655/15586
dc.description.abstractBackgroundThe purpose of this study was to determine the long-term prognostic implications of incidental pleural effusion (PE) detected during echocardiographic examination and its relationship with concomitant diseases. HypothesisThe study hypothesis is to test whether incidental pleural PE detected during echocardiographic examination be used as a prognostic marker. MethodsThe study was performed by evaluating patient records (N=251) in whom PE was incidentally detected during echocardiographic examination in a tertiary hospital between 1999 and 2012. The patients were classified into 4 major groups according to the concomitant primary disease: malignancy, and cardiovascular, renal, and pulmonary diseases. The total survival time was obtained from hospital records for patients who died during the hospital stay and social security institution records for patients with out-of-hospital death. ResultsOne-year and 5-year life expectancies of PE cases concomitant with different disorders were as follows; heart failure (n=151), 81% and 70%; malignancies (n=45), 53% and 44%; pulmonary diseases (n=37), 89% and 78%; renal diseases (n=18), 100% and 83%; respectively. PE associated with heart failure, renal disease, and pulmonary disease had similar (P > 0.05 for all) and favorable outcomes compared to PE associated with malignancies (P < 0.001). ConclusionsThe prognosis of incidental PE was the worst in patients with concomitant malignancies; however, PE associated with nonmalignant diseases including heart failure, pulmonary disease, and renal disease have similar and favorable outcomes.
dc.language.isoen
dc.publisherWiley
dc.relation.isversionof10.1002/clc.22239
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCardiovascular System & Cardiology
dc.titlePrognostic Role of Incidental Pleural Effusion Diagnosed During Echocardiographic Evaluation
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalClinical Cardiology
dc.contributor.departmentKardiyoloji
dc.identifier.volume37
dc.identifier.issue2
dc.identifier.startpage115
dc.identifier.endpage118
dc.description.indexWoS


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster